TAF5

Transcription initiation factor TFIID subunit 5 · Q15542 · TAF5 on Sugi Atlas →

0 patent compounds predicted against TAF5, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TAF5 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients PHASE3UNKNOWN
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma PHASE1/PHASE2COMPLETED
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor PHASE1/PHASE2NOT_YET_RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Vorinostat in Children PHASE1/PHASE2COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load PHASE1COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma PHASE1WITHDRAWN
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors PHASE1COMPLETED
Spironolactone and XPB-1 Integrity in the TFIIH Complex nanENROLLING_BY_INVITATION
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults nanCOMPLETED
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
Telomere and Telomerase nanWITHDRAWN
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. nanUNKNOWN
Immune Interactions in Severe Asthma nanCOMPLETED
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients nanACTIVE_NOT_RECRUITING
Family Resilience Initiative Research Program nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a TAF5 binder may also engage these)

ProteinNameSimilarity
Q8C092 1.000 Q8C092 →
Q8QFR2 0.985 Q8QFR2 →
Q8CGF6 0.983 Q8CGF6 →
CHAF1B Chromatin assembly factor 1 subunit B 0.983 landscape →
O94967 0.981 O94967 →
Q8VDD9 0.981 Q8VDD9 →
Q9H8E8 0.981 Q9H8E8 →
Q8WWQ0 0.980 Q8WWQ0 →
MAP4K5 Mitogen-activated protein kinase kinase kinase kinase 5 0.980 landscape →
Q8BPM2 0.980 Q8BPM2 →
Q8CID0 0.979 Q8CID0 →
P70483 0.979 P70483 →
O43815 0.979 O43815 →
Q9R1A8 0.979 Q9R1A8 →
PI4KB Phosphatidylinositol 4-kinase beta 0.978 landscape →
O42611 0.978 O42611 →
Q8WXG6 0.978 Q8WXG6 →
B0KWC1 0.978 B0KWC1 →
Q676U5 0.977 Q676U5 →
Q5RAC9 0.977 Q5RAC9 →
B1MTG7 0.977 B1MTG7 →
B2KI64 0.977 B2KI64 →
Q80U28 0.977 Q80U28 →
Q8NHY2 0.977 Q8NHY2 →
Q921C3 0.977 Q921C3 →
A4IID4 0.977 A4IID4 →
Q91V09 0.977 Q91V09 →
MAP4K3 Mitogen-activated protein kinase kinase kinase kinase 3 0.976 landscape →
Q924I2 0.976 Q924I2 →
Q9Y2L5 0.976 Q9Y2L5 →